| Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer (NCT00062231) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-04-01 |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy (NCT00310115) | M.D. Anderson Cancer Center | 2002-04-01 |
| VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome (NCT00049686) | Vion Pharmaceuticals | 2002-04-01 |
| Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia (NCT00045422) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Pyroxamide in Treating Patients With Advanced Cancer (NCT00042900) | Memorial Sloan Kettering Cancer Center | 2002-04-01 |
| Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy (NCT00303719) | Masonic Cancer Center, University of Minnesota | 2002-03-26 |
| Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer (NCT00031980) | Alliance for Clinical Trials in Oncology | 2002-03-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders (NCT00053989) | Roswell Park Cancer Institute | 2002-01-29 |
| Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignances (NCT00353860) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-01-23 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder (NCT00049634) | Fred Hutchinson Cancer Center | 2002-01-01 |
| STI571 in Treating Patients With Recurrent Leukemia (NCT00004932) | Children's Oncology Group | 2002-01-01 |
| Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00301912) | University of California, San Francisco | 2002-01-01 |
| Light-Emitting Diode Therapy in Preventing Mucositis in Children Receiving Chemotherapy With or Without Radiation Therapy Before Bone Marrow Transplantation (NCT00036712) | Medical College of Wisconsin | 2002-01-01 |
| FR901228 in Treating Patients With Hematologic Cancer (NCT00024180) | Ohio State University Comprehensive Cancer Center | 2002-01-01 |
| Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML (NCT00069992) | Baylor College of Medicine | 2001-12-01 |
| Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell Support (NCT00070616) | Swedish Orphan Biovitrum | 2001-12-01 |
| Genome Expression in Lymphoma, Leukemia and Multiple Myeloma (NCT00339963) | National Cancer Institute (NCI) | 2001-11-09 |
| Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy (NCT00055718) | Herbert Irving Comprehensive Cancer Center | 2001-11-01 |
| Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma (NCT00047021) | Case Comprehensive Cancer Center | 2001-11-01 |
| Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy (NCT00030108) | National Institutes of Health Clinical Center (CC) | 2001-11-01 |
| Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders (NCT00544115) | City of Hope Medical Center | 2001-10-16 |
| Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00027924) | Fred Hutchinson Cancer Center | 2001-10-01 |
| Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL (NCT00041288) | University of Texas Southwestern Medical Center | 2001-10-01 |
| Blood and Marrow Transplant Clinical Research Network (NCT00023530) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-09-01 |
| Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia (NCT00020865) | Jonsson Comprehensive Cancer Center | 2001-09-01 |
| Thalidomide in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00030550) | Roswell Park Cancer Institute | 2001-09-01 |
| Megadose CD34 Selected Progenitor Cells for Transplantation in Patients With Advanced Hematological Malignant Diseases (NCT00038857) | M.D. Anderson Cancer Center | 2001-09-01 |
| S0020 Immunosuppressive Therapy in Treating Patients With Myelodysplastic Syndrome (NCT00016419) | SWOG Cancer Research Network | 2001-08-01 |
| Bevacizumab in Treating Patients With Myelodysplastic Syndrome (NCT00022048) | Stanford University | 2001-08-01 |
| S0112 Cytarabine and Daunorubicin in Treating Older Patients With Acute Myeloid Leukemia (NCT00023777) | SWOG Cancer Research Network | 2001-08-01 |
| Total-Body Irradiation and Chemotherapy Followed By Donor Bone Marrow Transplant in Treating Young Patients With Hematologic Cancer (NCT00028730) | Memorial Sloan Kettering Cancer Center | 2001-08-01 |
| Alemtuzumab Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Lymphocytic Leukemia (NCT00006390) | Eastern Cooperative Oncology Group | 2001-07-05 |
| Bortezomib in Treating Patients With Chronic Myelogenous Leukemia (NCT00023881) | M.D. Anderson Cancer Center | 2001-07-02 |
| Late Chronic Phase Chronic Myelogenous Leukemia (NCT01092741) | M.D. Anderson Cancer Center | 2001-07-01 |
| Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00027560) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia (NCT01108497) | Stanford University | 2001-07-01 |
| Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia (NCT00017342) | Virginia Commonwealth University | 2001-07-01 |
| Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients (NCT00195533) | Wyeth is now a wholly owned subsidiary of Pfizer | 2001-07-01 |
| Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia (NCT00027547) | Fred Hutchinson Cancer Center | 2001-07-01 |
| Study of Farnesyl Protein Transferase Inhibitor (FPTI) in Patients With Leukemia (Study P00701) (NCT00034684) | Merck Sharp & Dohme LLC | 2001-07-01 |
| Fludarabine and Cyclophosphamide With or Without Oblimersen in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT00024440) | Genta Incorporated | 2001-07-01 |
| Safety and Efficacy of Campath in Nonmyeloablative Transplantation (NCT00038844) | M.D. Anderson Cancer Center | 2001-06-01 |
| Tipifarnib in Treating Young Patients With Refractory Leukemia (NCT00022451) | National Institutes of Health Clinical Center (CC) | 2001-06-01 |
| Trial of Allogeneic Stem Cell Transplants From HLA Compatible, Related and Unrelated Donors After a Myeloablative Preparative Regimen With Hyperfractionated TBI, Thiotepa and Fludarabine For Adult Patients With Lymphohematopoietic Disorders (NCT00587054) | Memorial Sloan Kettering Cancer Center | 2001-06-01 |
| TITLE:Less Intensive Therapy for Children With Non-Hodgkin's Lymphoma (NCT00002757) | Children's Oncology Group | 2001-06-01 |
| Imatinib Mesylate Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia (NCT00022490) | OHSU Knight Cancer Institute | 2001-06-01 |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT00274807) | The Cleveland Clinic | 2001-06-01 |
| Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome (NCT00053001) | Fallon Clinic | 2001-06-01 |
| STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia (NCT00015860) | Jonsson Comprehensive Cancer Center | 2001-05-01 |
| Doxorubicin Hydrochloride Liposome and Bortezomib in Treating Patients With Refractory Hematologic Cancer or Malignant Solid Tumor or Metastatic Breast Cancer (NCT00237627) | UNC Lineberger Comprehensive Cancer Center | 2001-05-01 |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS (NCT00025662) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-05-01 |
| Nonmyeloablative Preparative Regimen Using Mylotarg for Patients With High Risk Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL), Chronic Myeloid Leukemia (CML) and Myelodysplastic Syndrome (MDS) (NCT00038805) | M.D. Anderson Cancer Center | 2001-05-01 |
| Phase II Trial of a Chemotherapy Alone Regimen of IV Busulfan (Busulfex), Melphalan and Fludarabine as Myeloablative Regimen Followed by an Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplant From an HLA-Identical, or HLA-Non Identical Related or Unrelated Donor (NCT00582933) | Memorial Sloan Kettering Cancer Center | 2001-05-01 |
| Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer (NCT00290641) | Masonic Cancer Center, University of Minnesota | 2001-04-01 |
| Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia (NCT00006462) | Children's Oncology Group | 2001-04-01 |
| Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers (NCT00015951) | University of Maryland, Baltimore | 2001-04-01 |
| Imatinib Mesylate and Cytarabine in Treating Patients With Newly Diagnosed Chronic Myeloid Leukemia (NCT00028847) | Commissie Voor Klinisch Toegepast Onderzoek | 2001-04-01 |
| Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes (NCT00020969) | CTI BioPharma | 2001-03-01 |
| Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT00006265) | Alliance for Clinical Trials in Oncology | 2001-03-01 |
| Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia (NCT00017108) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-03-01 |
| Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia (NCT00038610) | M.D. Anderson Cancer Center | 2001-03-01 |
| Caspofungin Acetate in Treating Children With Fever and Neutropenia (NCT00020527) | National Cancer Institute (NCI) | 2001-03-01 |
| Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT00020670) | Dana-Farber Cancer Institute | 2001-02-20 |
| Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML (NCT00003407) | Rush University Medical Center | 2001-02-13 |
| Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome (NCT00024050) | Fred Hutchinson Cancer Center | 2001-02-01 |
| Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma (NCT00006252) | Cancer and Leukemia Group B | 2001-02-01 |
| Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia (NCT00006084) | Jonsson Comprehensive Cancer Center | 2001-02-01 |
| MS-275 in Treating Patients With Hematologic Cancer (NCT00015925) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2001-02-01 |
| Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia (NCT00030303) | UConn Health | 2001-01-01 |
| Denileukin Diftitox in Treating Patients With Non-Hodgkin's Lymphoma (NCT00026429) | Pharmatech Oncology | 2001-01-01 |
| Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia (NCT00012259) | Shire | 2000-12-11 |
| Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer (NCT00014469) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer (NCT00006239) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2000-12-01 |
| Oblimersen and Gemtuzumab Ozogamicin in Treating Older Patients With Relapsed Acute Myeloid Leukemia (NCT00017589) | Genta Incorporated | 2000-12-01 |
| Pentostatin and Rituximab in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00026351) | Pharmatech Oncology | 2000-12-01 |
| Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer (NCT00054327) | Case Comprehensive Cancer Center | 2000-11-01 |
| Busulfan in Treating Children and Adolescents With Refractory CNS Cancer (NCT00006246) | Pediatric Brain Tumor Consortium | 2000-11-01 |
| Chemotherapy Plus Monoclonal Antibody in Treating Patients With Acute Promyelocytic Leukemia (NCT00016159) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With Advanced Myeloid Cancer (NCT00014495) | Memorial Sloan Kettering Cancer Center | 2000-11-01 |
| Comparison of Three Treatment Regimens in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia (NCT00005962) | Eastern Cooperative Oncology Group | 2000-10-04 |
| Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment (NCT00006348) | Alliance for Clinical Trials in Oncology | 2000-10-01 |
| Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation (NCT00005946) | University of Maryland, Baltimore | 2000-10-01 |
| Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT00008151) | Fred Hutchinson Cancer Center | 2000-10-01 |
| Phenylbutyrate, Dexamethasone, and Sargramostim in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia (NCT00006240) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-10-01 |
| Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia (NCT00014560) | Dartmouth-Hitchcock Medical Center | 2000-09-28 |
| Sleep, Fatigue, and Dexamethosone in Children With Leukemia (NCT00075101) | National Institute of Nursing Research (NINR) | 2000-09-01 |
| Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia (NCT00613457) | Associazione Italiana Ematologia Oncologia Pediatrica | 2000-09-01 |
| Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia (NCT00005977) | Children's Oncology Group | 2000-09-01 |
| STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis (NCT00006475) | Novartis | 2000-09-01 |
| Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00012207) | Fred Hutchinson Cancer Center | 2000-09-01 |
| Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT (NCT00506922) | M.D. Anderson Cancer Center | 2000-09-01 |
| Allogeneic Transplantation From Related Haploidentical Donors (NCT00185692) | Stanford University | 2000-08-01 |
| Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission (NCT00305708) | University of California, San Francisco | 2000-08-01 |
| A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy (NCT00261677) | Ortho Biotech Products, L.P. | 2000-08-01 |
| Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia (NCT00005984) | Masonic Cancer Center, University of Minnesota | 2000-08-01 |
| Tipifarnib in Treating Patients With Advanced Hematologic Cancer (NCT00005967) | National Cancer Institute (NCI) | 2000-08-01 |
| Arsenic Trioxide for Induction Therapy of Adult Patients With Leukemia (NCT00006092) | H. Lee Moffitt Cancer Center and Research Institute | 2000-08-01 |
| Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia (NCT00022035) | Roswell Park Cancer Institute | 2000-08-01 |
| Brain Neoplasms, Leukemia and Petrochemical Exposures (NCT00042445) | National Institute of Environmental Health Sciences (NIEHS) | 2000-08-01 |